Birgit St Norinder
has held several senior Research and Development positions in European and US based Pharmaceutical Companies including Pharmacia & Upjohn (UK) as a member of Corporate Management and Senior Vice-President Worldwide Product Development, Glaxo Group Research Ltd (UK) as Director of International Regulatory Affairs, Astra Research Centre AB (Sweden) as Vice-President of Infection R&D, Pfizer Inc (USA) and Parke-Davis AB (Sweden). Mrs Stattin Norinder has served as Chief Executive Officer and Chairman of Prolifix Ltd (UK). She has also held several Board and Chairman positions of UK, Swedish and Norwegian biotechnology companies. At present she is a Board Member of Hansa Medical AB and Jettesta AB in Sweden Mrs Stattin Norinder has a Master of Pharmaceutical Sciences from Uppsala University.